Sutro Biopharma, Inc. (STRO): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$4.06M
As of 2023-12-31
-45.1%
3-year compound annual growth
-22.7%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $4.06M | -75.0% | 2024-03-25, Balance as of period end |
| 2022-12-31 | $16.27M | -35.2% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $25.11M | +2.3% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $24.55M | n/a | 2022-02-28, Balance as of period end |
| No annual figure between 2018-12-31 and 2020-12-31. | |||
| 2018-12-31 | $14.72M | n/a | 2019-04-01, Balance as of period end |